2023
Medicine
United Kingdom and United States
Approved CRISPR therapy
Casgevy becomes the first authorised gene-editing treatment, for sickle cell disease.
Why it mattered
Gene editing moves from laboratory to pharmacy.
Information Age
2023
1 recorded milestone at this point in the record.
Sign in to amend this page or add a milestone — every edit is signed and kept in the record.